Solvac revenue and financials
€88.50Change from previous close: −0.56%Absolute change: −€0.50
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Net income growth
- +19.69%
- 2025 vs 2024
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Cost of revenue | 2.7 | 2.1 | 2.0 | 1.6 | — |
| Gross profit | -2.7 | -2.1 | -2.0 | -1.6 | — |
| Operating income | -3.1 | -2.5 | -2.6 | -1.9 | — |
| EBIT | 129 | 108 | 130 | 125 | — |
| EBITDA | 129 | 108 | 130 | 125 | — |
| Interest expense | 3.2 | 3.4 | 3.1 | 2.9 | — |
| Pre-tax income | 125 | 105 | 127 | 122 | — |
| Income tax | 0.0 | 0.0 | -0.0 | 0.0 | — |
| Net income | 125 | 105 | 127 | 122 | — |
| Net income to common shareholders | 125 | 105 | 127 | 122 | — |
| Basic EPS | — | 4.90 | 5.96 | 5.71 | 13.70 |
| Diluted EPS | — | 4.90 | 5.96 | 5.71 | 13.70 |
| Average shares (basic) | — | 21.4 | 21.4 | 21.4 | 21.4 |
| Average shares (diluted) | 21.4 | 21.4 | 21.4 | 21.4 | — |